Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.

Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C, Peter N, Dölken G, Becker C, Heyn S, Kliem C, Lange T, Krahl R, Pönisch W, Fricke HJ, Sayer HG, Al-Ali H, Kamprad F, Niederwieser D; East German Study Group Hematology and Oncology (OSHO).

Leukemia. 2009 Apr;23(4):635-40. doi: 10.1038/leu.2008.352. Epub 2009 Jan 8.

PMID:
19151786
2.

Molecular characterization of acute myeloid leukemia.

Döhner K, Döhner H.

Haematologica. 2008 Jul;93(7):976-82. doi: 10.3324/haematol.13345. No abstract available.

3.

MicroRNA expression in cytogenetically normal acute myeloid leukemia.

Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P, Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL, Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD.

N Engl J Med. 2008 May 1;358(18):1919-28. doi: 10.1056/NEJMoa074256.

4.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H; German-Austrian Acute Myeloid Leukemia Study Group.

N Engl J Med. 2008 May 1;358(18):1909-18. doi: 10.1056/NEJMoa074306.

5.

Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.

Hamadani M, Awan FT, Copelan EA.

Biol Blood Marrow Transplant. 2008 May;14(5):556-67. doi: 10.1016/j.bbmt.2008.02.019. Review.

6.

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review.

Oliansky DM, Appelbaum F, Cassileth PA, Keating A, Kerr J, Nieto Y, Stewart S, Stone RM, Tallman MS, McCarthy PL Jr, Hahn T.

Biol Blood Marrow Transplant. 2008 Feb;14(2):137-80. doi: 10.1016/j.bbmt.2007.11.002. Review.

7.

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R.

Blood. 2007 Dec 15;110(13):4606-13. Epub 2007 Sep 14.

8.

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Cornelissen JJ, van Putten WL, Verdonck LF, Theobald M, Jacky E, Daenen SM, van Marwijk Kooy M, Wijermans P, Schouten H, Huijgens PC, van der Lelie H, Fey M, Ferrant A, Maertens J, Gratwohl A, Lowenberg B.

Blood. 2007 May 1;109(9):3658-66. Epub 2007 Jan 9.

9.

Acute myeloid leukaemia.

Estey E, Döhner H.

Lancet. 2006 Nov 25;368(9550):1894-907. Review.

PMID:
17126723
10.

Long-term results of the MRC AML10 trial.

Burnett AK, Wheatley K, Goldstone AH, Stevens R, Hann I, Hills RK.

Clin Adv Hematol Oncol. 2006 Jun;4(6):445-51. No abstract available.

PMID:
16981667
11.

Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.

Visani G, Olivieri A, Malagola M, Brunori M, Piccaluga PP, Capelli D, Pomponio G, Martinelli G, Isidori A, Sparaventi G, Leoni P.

Leuk Lymphoma. 2006 Jun;47(6):1091-102.

PMID:
16840201
12.

Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience.

Jourdan E, Boiron JM, Dastugue N, Vey N, Marit G, Rigal-Huguet F, Molina L, Fegueux N, Pigneux A, Recher C, Rossi JF, Attal M, Sotto JJ, Maraninchi D, Reiffers J, Bardou VJ, Esterni B, Blaise D.

J Clin Oncol. 2005 Oct 20;23(30):7676-84. Epub 2005 Sep 26.

PMID:
16186596
13.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.

Blood. 2005 Oct 15;106(8):2912-9. Epub 2005 Jun 30.

15.
16.

Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.

Brunet S, Esteve J, Berlanga J, Ribera JM, Bueno J, Martí JM, Bargay J, Guardia R, Juliá A, Granena A, Montserrat E, Sierra J; Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias.

Haematologica. 2004 Aug;89(8):940-9.

17.

Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission.

Levi I, Grotto I, Yerushalmi R, Ben-Bassat I, Shpilberg O.

Leuk Res. 2004 Jun;28(6):605-12.

PMID:
15120937
18.

Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis.

Nathan PC, Sung L, Crump M, Beyene J.

J Natl Cancer Inst. 2004 Jan 7;96(1):38-45.

PMID:
14709737
19.

Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.

Schlenk RF, Benner A, Hartmann F, del Valle F, Weber C, Pralle H, Fischer JT, Gunzer U, Pezzutto A, Weber W, Grimminger W, Preiss J, Hensel M, Fröhling S, Döhner K, Haas R, Döhner H; AML Study Group Ulm (AMLSG ULM).

Leukemia. 2003 Aug;17(8):1521-8.

PMID:
12886238
20.

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.

Suciu S, Mandelli F, de Witte T, Zittoun R, Gallo E, Labar B, De Rosa G, Belhabri A, Giustolisi R, Delarue R, Liso V, Mirto S, Leone G, Bourhis JH, Fioritoni G, Jehn U, Amadori S, Fazi P, Hagemeijer A, Willemze R; EORTC and GIMEMA Leukemia Groups.

Blood. 2003 Aug 15;102(4):1232-40. Epub 2003 Apr 24.

Supplemental Content

Support Center